Initial Experience With Novel Oral Anticoagulants During the First 45 Days After Left Atrial Appendage Closure With the Watchman Device.

Bösche, Leif I

Initial Experience With Novel Oral Anticoagulants During the First 45 Days After Left Atrial Appendage Closure With the Watchman Device. [electronic resource] - Clinical cardiology Dec 2015 - 720-4 p. digital

Publication Type: Journal Article

1932-8737

10.1002/clc.22478 doi


Administration, Oral
Aged
Aged, 80 and over
Anticoagulants--adverse effects
Atrial Appendage--drug effects
Cardiac Surgical Procedures--adverse effects
Dabigatran--adverse effects
Echocardiography, Transesophageal
Feasibility Studies
Female
Follow-Up Studies
Humans
Male
Middle Aged
Pilot Projects
Retrospective Studies
Rivaroxaban--adverse effects
Stroke--etiology
Survival Rate
Thrombosis--etiology
Treatment Outcome